District Of Columbia 2025 2025-2026 Regular Session

District Of Columbia Council Bill PR26-0027 Introduced / Bill

Filed 01/08/2025

                    ��� ����	������ �
����� �
�1�D�b
�l�D�g�v�y	� ��y	�	����y
�?
�Z�I�y	�/�d�b�d�g�D�E�]�I�y	�:�Z�[�]�y	�4�I�b�H�I�]�j�d�b�y
�'�Z�D�[�g�`�D�b�y
�'�d�l�b�G�[�]�y	�d�J�y	�k�Z�I�y	�(�[�j�k�g�[�G�k�y	�d�J�y	�'�d�]�m�`�F�[�D�y
�1�d�Z�b�y	�%��y	�B�[�]�j�d�b�y	�&�l�[�]�H�[�b�Y�y
�����;�I�b�c�j�v�]�p�D�b�[�D�y	�%
�p�I	�b�l�I��7	�B��y	�>�l�[�k�I�y	����y
�B�D�j�Z�[�b�Y�k�d�b��y	�)
�'�y	������y
�(�I�D�g�y	�'�Z�D�[�h�`�D�b�y	�5
�I�b�H�I�]�j�d�b�"�y
�0�b�y	�D�G�G�d�g�H�D�b�G�I	�y �r�[�k�Z
�y �j�I�G�k�[�d�b�y	��y �d�J�y	�k�Z�I�y	�'�d�b�R�g�`�D�k�[�d�b�y	�%�G�k�y	�d�J	�y��!�� ��y	�I	�M�I�G�k�[�p�I	�y �5�D�g�G�Z�y	��	�y��!��!�y	��(��'�	�y �2�D�r�y	��	�y
��
� �$�y �(��'��y	�8�O�G�[�D�^�y	�'�d�H�I�y	�x�y ���������y	��	�y�D�b�H	�y �e�m�g�j�m�D�b�k�y	�k�d�y	�j�I�G�k�[�d�b	�y �����y	�d�K�y	�k�Z�I�y	�-�D�k�D�_�[�k�w�y	�<�I�p�[�I�r�y	�'�d�`�`�[�k�k�I�I�y
�%
�`	�I�b�H�`�I�b�k�y	�%�G�k�y	�d�J�y	���� ��y	�I�N�I�G�k�[�p�I	�y �8�G�k�d�E�I�g�y	����y	���� 	�y ��(��'�	�y �3�D�r�y	�	� ���� �$�y	�(��'��y	�8�P�G�[�D�]�y	�'�d�H�I�y	�x�y	�	� �y
����������y	�0�y �D�`�y	�e
�]�I�D�j�I�H	�y �k�d�y	�b�d�`�[�b�D�k�I�y	�k�Z�I�y	�V�]�]�d�s�[�b�Y�y	�[	�b�H�[�q�[�H�n�D�]�#�y
�(�g��y	�+�g�[�G�D�y	�<�[�G�Z�D�g�H�j�y
�0�g�[�j�y	�>�k�h�I�I�k��y	�7�B�y
�B�D�j�Z�[�b�Y�k�d�b��y	�(�'�y	������y
��B�D�g�H�y	���y
�V�g�y	�g�I�D	�e
�e �d�[�b�k�`�I�b�k�y	�D�j�y	�D�y �g�I�e�g�I�j�I�b�k�D�k�[�p�I�y	�X	�d�`�y	�D�y �Z�d�j�e�[�k�D�]�y	�]�d�G�D�k�I�H�y	�[�b�y	�k�Z�I�y	�*�[�j�k�g�[�G�k�y	�d�J�y	�'�d�]�m�`�E�[�D�y	�`�I�`�E�I�g�y	�d�J�y
�k�Z�I�y	�A�[�d�]�I�b�G�I�y	�.�D�k�D�]�[
�k�w�y	�=�I�p�[�I�r�y	�'�d�`�`�[�k�k�I�I��y	�V�g�y	�D�y �k�I�g�`�y	�k�d�y	�I�b�H�y	�8�G�k�d�E�I�g�y	����y	������y
�,�b�G�]�d�j�I�H��y	�w�d�l�y	�t�[�]�]	�y �S
�b�H�y	�E�[�d�Y�g�D�e�Z�[�G�D�]�y	�[�b�W�g�a�D�k�[�d�b�y	�H�I�k�D�[�]�[�b�Y�y	�k�Z�I�y	�I�u�e�I�g�[�I�b�G�I�y	�d�J	�y�k�Z�I�y	�D�E�d�p�I��a�I�b�k�[�d�c�I�H�y
�b�d�a�[�b�I�I��y	�k�d�Y�I�k�Z�I�g�y
	�D �y�e�g�d�e�d�j�I�H�y	�g�I�j�d�]�l�k�[�d�b�y	�k�d	�y�D�j�j�[�j�k	�y�k�Z�I�y	�'�d�l�c�G�[�]�y	�H�l�g�[�b�Y�y	�k�Z�I�y	�G�d�b�T�i�a�D�k�[�d�b�y	�e	�g�d�G�I�j�j��y
�0�y �t�d�l�]�H�y	�D�e�e�g�I�G�[�D�k�I�y�k�Z�I�y	�'�d�l�b�G�[�]��j�y	�I�D�g�]�[�I�j�k�y	�G�d�b�j�[�H�I�g�D�k�[�d�b	�y�d�J
�y�k�Z�[�j�y	�c	�d�a�[�b�D�k�[�d�b	�y�W�g�y	�G�d�b�U�i�a�D�k�[�d�c��y	�:�]�I�D�j�I�y
�H�d�y	�c�d�k
�y �Z	�I�j	�[�k�D�k�I�y	�k�d�y	�G�d�b�k�D�G�k�y	�`�I��y	�d�g�y	�>�k�I�p�I�b�y	�C�D�]�\�I�g��y	�(�[�g�I�G�k�d�g��y	�6�D�w�d�g��j	�y �9�Q�G�I�y	�d�L�y	�@�D�]�I�b�k�y	�D�b�H�y
�%�e�e�d�[�b�k�a�I�b�k�j��y	�j�Z�d�l�]�H�y	�k�Z�I�y	�'�d�l�b�G�[�]�y	�g�I�f�o�[�g�I�y	�D�H�H�[	�k�[�d�c�D�]�y	�[�b�V�g�a�D�k�[�d�b��y 1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
A PROPOSED RESOLUTION 
~~ 
Chairman Phil Mendelson 
at the request 
of the Mayor 
IN THE COUNCIL OF THE DISTRICT OF COLUMBIA 
To confirm the reappointment 
of Dr. Erica Richards to the Violence Fatality Review Committee. 
RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this 
resolution may be cited as the "Violence Fatality Review Committee Dr. Erica Richards 
Confirmation Resolution 
of 2025". 
Sec. 
2. The Council of the District of Columbia confirms the reappointment of: 
Dr. Erica Richards 
Iris Street, 
NW 
Washington, DC 20012 
(Ward 4) 
as a representative 
of a hospital located in the District 	of Columbia member of the Violence 
Fatality Review Committee, established by section 3042 
of the Fatality Review Committee 
Amendment Act 
of 2018, effective October 30, 2018 (D.C. Law 22-168; D.C. Official 	Code§ 5-
1431.01), for a term to end October 
12, 2027. 
Sec. 
3. The Council of the District of Columbia shall transmit a copy 	of this resolution, 
upon its adoption, to the nominee and to the Office 
of the Mayor. 
Sec. 4. This resolution shall take effect immediately .   EricaMartinRichards,MD,PhD
CURRICULUMVITAE
DEMOGRAPHICANDPERSONALINFORMATION
ContactInformatio!
 
CurrentAppointments
October2017-PresentChairandMedicalDirector
DepartmentofPsychiatryandBehavioralHealth
SibleyMemorialHospital
5255LoughboroRoad,NW
Washington,DC20016
October2017-PresentAssistantProfessor
PersonalData
DepartmentofPsychiatryandBehavioralSciences
TheJohnsHopkinsSchoolofMedicine
733NBroadwayStreet
Baltimore,MD21205
EducationandTraining
Undergraduate:
GraduateEducation:
MedicalEducation:
SpelmanCollege,Atlanta,GA.BS.
350SpelmanLane
Atlanta,GA30314
August1995-May1999
BS.Biology,CumLaude.
UniversityofMarylandSchoolofMedicine
655W.BaltimoreStreet
Baltimore,MD21201
July2001-May2006
DoctorofPhilosophyinNeuroscience
PrimaryMentor:GaryFiskum,PhD
UniversityofMarylandSchoolofMedicine
655W.BaltimoreStreet   EricaM.Richards,MD,PhD CurriculumVitae	Page2of11
Internship:
Residency:
Fellowship:
Baltimore,MD21201
‘August1999-May2008(CombinedMD/PhDProgram)
DoctorofMedicine
CombinedPsychiatry-InternalMedicineInternship
JohnsHopkinsBayviewMedicalCenter
5300AlphaCommonsDrive
Baltimore,MD.21224
July2008-June2009
ConstantineLyketsos,MD-DepartmentChair
TheJohnsHopkinsHospital
DepartmentofPsychiatryandBehavioralSciences
AdultPsychiatryResidencyProgram
600N.WolfeStreet
Baltimore,MD21287
July2009-June2012(AdministrativeResident2010-2011)
J.RaymondDePaulo,Jr.,MD~DepartmentChair
TheNationalInstitutesofHealth
ClinicalResearchFellowshipattheNationalInstituteofMentalHealth
10CenterDrive
CRC-Building10,room6-5340
Bethesda,Maryland20892-1276
September2012-September2015
JoyceChung,MD—FellowshipDirector
PriorProfessionalExperience:
2015-2017
2016-2017
2011-2012
AttendingPhysician
PsychiatricConsultationService
OfficeoftheClinicalDirector
NationalInstituteofMentalHealth
10CenterDrive
CRC-Building10,room6-5340
Bethesda,Maryland20892-1276
AssistantProfessorofPsychiatry
GeorgetownUniversityMedicalCenter
3900ReservoirRoad,NW
Med-DentBuilding,RoomNW208
Washington,DC20057
July2016-present
ChiefResident
DepartmentofPsychiatryandBehavioralSciences
‘AdultPsychiatryResidencyProgram   EricaM.Richards,MD,PhD CurriculumVitae	Page3of11
TheJohnsHopkinsHospital
2012-2017 PrivatePracticePhysician
EricaRichards,MD,PhD,LLC
5480WisconsinAvenue
ChevyChase,MD
PUBLICATIONS
i.OriginalResearch
10.
‘WyseR,Hwang,W,Ahmed,A,RichardsE,DevilleC.DiversitybyRace,Ethnicity,andSexwithintheUS
PsychiatryPhysicianWorkforce.2020July23.Doi10.1007.PMID32705570.
BallardED,YarringtonJS,FarmerCA,RichardsE,Machado-VieiraR,KadriuB,NiciuMJ,YuanP,ParkL,
ZarateCAJr.CharacterizingtheCourseofSuicidalIdeationResponsetoKetamine.JAffectiveDisorders.
2018Dec1:241:86-93.Doi10.1016.Epub2018Jul30.PMID30099268.
RichardsEM,Zanotti-FregonaraP,FujitaM,NewmanL,FarmerC,BallardED,Machado-VieiraR,YuanP,
NiciuMJ,LyooCH,HenterID,SalvadoreG,DrevetsWC,KolbH,InnisRB,ZarateCAJr.PETRadioligand
BindingtoTranslocatorProtein(TSPO)isincreasedinUnmedicationDepressedSubjects.EINMMI
Research.2018Jul3:8(1):57.doi:10.1186/s13550-018-0401-9,PMID29971587
VandeVoortJt,BallardED,LuckenbaughDA,BernertRA,RichardsEM,NiciuMi,ParkLT,Machado-
VieiraR,DuncanWCJr,ZarateCAJr.AntisuicidalResponseFolloingKetamineInfusionisAssociatedwith
DecreasedNighttimeWakefulnessinMajorDepressiveDisorderandBipolarDisorder.JClinPsychiatry.
2017Sep/Oct;78(8):1068-1074,doi:10.4088
BallardED,WillsK,LallyN,RichardsEM,LuckenbaughDA,WallsT,AmeliR,NiciuMJ,BrutscheNE,Park
ZarateCAJr.AnhedoniaasaClinicalCorrelateofSuicidalThoughtsinClinicalKetamineTrials.JAffect
Disord.2017Aug15;218:195-200.doi:10.1016/j.jad.017.04.057.PMID:28477497.
FujitaM,RichardsEM,NiciuMJ,lonescuDF,ZoghbiSS,HongJ,TeluS,HinesCS,PikeVW,ZarateCA,
InnisRB.cAMPSignalinginBrainisDecreasedinUnmedicatedDepressedPatientsandIncreasedby
TreatmentwithaSelectiveSerotoninReuptakeInhibitor.MolPsychiatry.2017May;22(5):754-759.doi:
10.1038/mp.2016.171.PMID:27725657.
BallardED,VandeVoortJL,BernertRA,LuckenbaughDA,RichardsEM,NiciuMJ,FureyML,DuncanWC
JR,ZarateCAJr.NocturnalWakefulnessisAssociatedwithNext-DaySuicidalIdeationinMajor
DepressiveDisorderandBipolarDisorder.JClinPsychiatry.2016Jun;77(6):825-31.Doi:10.4088/JCP.
PMID27337418.
Machado-VieiraR,GoldPW,LuckenbaughDA,BallardED,RichardsEM,HenterID,DeSousaRT,Niciu
M4,YuanP,ZarateCAJr.TheRoleofAdipokinesintheRapidAntidepressantEffectsofKetamine.Mol
Psychiatry.2016Apr5.doi:10.1038/mp.2016.36.[Epubaheadofprint]PMID:27046644.Role:bench
scientificexperimentsinvolvinganalysisofplasmaandsubsequentdataanalysis;patientscreensand
ongoingevaluation,writingofMethodsandResultssections.
JasoBA,NiciuMJ,ladarolaND,LallyN,RichardsEM,ParkM,BallardED,NugentAC,Machado-VieiraR,
ZarateCAJr.TherapeuticModulationofGlutamateReceptorsinMajorDepressiveDisorder.Curr
Neuropharmacol.2016Mar21.[Epubaheadofprint].PMID:26997505.Role:Clinicaltrial-mentorship
ofprimaryauthor,dataanalysis;patientscreensandongoingevaluation,writingofMethodsand
Resultssections.
RichardsEM,MathewsDC,LuckenbaughDA,lonescuDF,Machado-VieiraR,NiciuMJ,DuncanWC,
NolanNM,Franco-ChavesJA,HudzikT,MaciagC,LiS,CrossA,SmithMA,ZarateCAJr.Arandomized,
placebo-controlledpilottrialofthedeltaopioidreceptoragonistAZD2327inanxiousdepression.
 
 
 
     EricaM.Richards,MD,PhD CurriculumVitae	Page4of11
1.
12.
13.
14,
15.
16.
17.
18.
19.
20.
Psychopharmacology(Berl).2016Mar;233(6):1119-30.doi:10.1007/s00213-015-4195-4,Epub2016Jan
4,PMID:26728893.
LallyN,AnL,BanerjeeD,NiciuMJ,LuckenbaughDA,RichardsEM,RoiserJP,ShenJ,ZarateCAJr,
NugentAC.Reliabilityof7T(1)H-MRSmeasuredhumanprefrontalcortexglutamate,glutamine,and
glutathionesignalsusinganadaptedechotimeoptimizedPRESSsequence:Abetween-andwithin-
sessionsinvestigation.JMagnResonImaging.2016Jan;43(1):88-98.doi:10.1002/jmri.24970.Epub2015
Jun7.PubMedPMID:26059603;PubMedCentralPMCID:PMC4671833.
BallardED,LuckenbaughDA,RichardsEM,WallsTL,BrutschéNE,AmeliR,NiciuMJ,VandeVoortJL,
ZarateCAJr.Assessingmeasuresofsuicidalideationinclinicaltrialswitharapid-actingantidepressant.J
PsychiatrRes.2015Sep;68:68-73.doi:10.1016/j,jpsychires.2015.06.003.Epub2015Jun16.PubMed
PMID:26228403;PubMedCentralPMCID:PMC4522045.
lonescuDF,LuckenbaughDA,NiciuMJ,RichardsEM,ZarateCAJr.Asingleinfusionofketamine
improvesdepressionscoresinpatientswithanxiousbipolardepression.BipolarDisord.2015
Jun;17(4):438-43.doi:10.1111/bdi.12277.Epub2014Nov14.PubMedPMID:25400146;PubMed
CentralPMCID:PMC4431955.
lonescuDF,NugentAC,LuckenbaughDA,NiciuMJ,RichardsEM,ZarateCA,FureyML.Baselineworking
memoryactivationdeficitsindimensionalanxiousdepressionasdetectedbymagnetoencephalography.
ActaNeuropsychiatr.2015Jun;27(3):143-52.doi:10.1017/neu.2014.46.Epub2015Jan20.PubMed
PMID:25600154,
ladarolaND,NiciuMJ,RichardsEM,VandeVoortJL,BallardED,LundinNB,NugentAC,Machado-
R,ZarateCAJr.KetamineandotherN-methyl-D-aspartatereceptorantagonistsinthetreatmentof
depression:aperspectivereview.TherAdvChronicDis.2015May;6(3):97-114.doi:
10.1177/2040622315579059.Review.PMID:25954495.
XuAJ,NiciuMJ,LundinNB,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BallardED,
BrutscheNE,Machado-VieiraR,ZarateCAJr.LithiumandValproateLevelsDoNotCorrelatewith
Ketamine’sAntidepressantEfficacyinTreatment-ResistantBipolarDepression.NeuralPlast.
2015;2015:858251.doi:10.1155/2015/858251.Epub2015Jun7.PubMedPMID:26137324;PubMed
CentralPMCID:PMC4475570.
NiciuMJ,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BallardED,BrutscheNE,FureyML,
ZarateCAJr.Riluzolelikelylacksantidepressantefficacyinketaminenon-responders.JPsychiatrRes.
2014Nov;58:197-9.doi:10.1016/j.jpsychires.2014.07.022.Epub2014Aug6.PubMedPMID:25139008;
PubMedCentralPMCID:PMC4300112.
BallardED,lonescuDF,VandeVoortJL,NiciuMJ,RichardsEM,LuckenbaughDA,BrutschéNE,AmeliR,
FureyML,ZarateCAJr.Improvementinsuicidalideationafterketamineinfusion:relationshipto
reductionsindepressionandanxiety.JPsychiatrRes.2014Nov;58:161-6.doi:
10.1016/j.jpsychires.2014.07.027.Epub2014Aug12.PubMedPMID:25169854;PubMedCentral
PMCID:PMC4163501.
‘NiciuMJ,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BallardED,BrutscheNE,FureyML,
ZarateCAJr.Ketamine'santidepressantefficacyisextendedforatleastfourweeksinsubjectswitha
familyhistoryofanalcoholusedisorder.IntJNeuropsychopharmacol.2014Oct31;18(1).pii:pyu039.
doi:10.1093/ijnp/pyu039.PubMedPMID:25539512;PubMedCentralPMCID:PMC4303351.
‘SvenningssonP,BergL,MatthewsD,lonescuDF,RichardsEM,NiciuMJ,MalingerA,ToupsM,ManjiH,
TrivediMH,ZarateCAJr,GreengardP.Preliminaryevidencethatearlyreductioninp11levelsinnatural
killercellsandmonocytespredictsthelikelihoodofantidepressantresponsetochroniccitalopram.Mol
 
 
  
   
 
 
 
   
    EricaM.Richards,MD,PhD CurriculumVitae	Page5of11
21.
22.
23.
24,
25.
26.
27.
28.
29.
30.
 
Psychiatry.2014Sep;19(9):962-4.doi:10.1038/mp.2014.13.Epub2014Mar11.PubMedPMID:
24614495;PubMedCentralPMCID:PMC4161667.
lonescuDF,LuckenbaughDA,NiciuMJ,RichardsEM,SlonenaEE,VandeVoortJL,BrutscheNE,Zarate
CA4Jr.Effectofbaselineanxiousdepressiononinitialandsustainedantidepressantresponseto
ketamine.JClinPsychiatry.2014Sep;75(9):e932-8.doi:10.4088/JCP.14m09049.PubMedPMID:
25295436.
LundinNB,NiciuMJ,LuckenbaughDA,lonescuDF,RichardsEM,VandeVoortJL,BrutscheNE,Machado-
VieiraR,ZarateCAJr.BaselinevitaminB12andfolatelevelsdonotpredictimprovementindepression
afterasingleinfusionofketamine.Pharmacopsychiatry.2014Jul;47(4-5):141-4,doi:10.1055/s-0034-
1377042.Epub2014Jun23.PubMedPMID:24955551;PubMedCentralPMCID:PMC4174587.
NiciuMJ,LuckenbaughDA,lonescuDF,GuevaraS,Machado-VieiraR,RichardsEM,BrutscheNE,Nolan
NM,ZarateCAJr.Clinicalpredictorsofketamineresponseintreatment-resistantmajordepression.J
Psychiatry.2014May;75(5):e417-23.doi:10.4088/JCP.13m08698.PubMedPMID:24922494;
PubMedCentralPMCID:PMC4310499.
LuckenbaughDA,NiciuMi,IonescuDF,NolanNM,RichardsEM,BrutscheNE,GuevaraS,ZarateCA.Do
thedissociativesideeffectsofketaminemediateitsantidepressanteffects?JAffectDisord.2014
Apr;159:56-61.doi:10.1016/j,jad.2014.02.017.Epub2014Feb18.PubMedPMID:24679390;PubMed
CentralPMCID:PMC4065787.
NiciuMJ,LuckenbaughDA,lonescuDF,MathewsDC,RichardsEM,ZarateCAJr.Subanestheticdose
ketaminedoesnotinduceanaffectiveswitchinthreeindependentsamplesoftreatment-resistant
majordepression.BiolPsychiatry.2013Nov15;74(10):e23-4.doi:10.1016/j.biopsych.2013.01.038.Epub
2013May28.PubMedPMID:23726512;PubMedCentralPMCID:PMC3805682.
RiceP,MartinE,HeJR,FrankM,DeTollaL,HesterL,O'NeillT,MankaC,Benjamin|,NagarsekarA,Singh
1,HasdayJD.Febrile-rangehyperthermiaaugmentsneutrophilaccumulationandenhanceslunginjuryin
experimentalgram-negativebacterialpneumonia.JImmunol.2005Mar15;174(6):3676-85.PubMed
PMID:15749906.
RichardsEM,RosenthalRE,KristianT,FiskumG.Postischemichyperoxiareduceshippocampalpyruvate
dehydrogenaseactivity.FreeRadicBiolMed,2006Jun1;40(11):1960-70.Epub2006Feb17.PubMed
PMID:16716897;PubMedCentralPMCID:PMC2570699.
RichardsEM,FiskumG,RosenthalRE,HopkinsI,McKennaMC.Hyperoxicreperfusionafterglobal
ischemiadecreaseshippocampalenergymetabolism.Stroke.2007May;38(5):1578-84.Epub2007Apr5.
PubMedPMID:17413048;PubMedCentralPMCID:PMC2601708.
MathewsDC,RichardsEM,NiciuMJ,lonescuDF,RasimasJJ,ZarateCAJr.NEUROBIOLOGICALASPECTS
OFSUICIDEANDSUICIDEATTEMPTSINBIPOLARDISORDER.Trans!Neurosci.2013Jun;4(2).doi:
10.2478/s13380-013-0120-7.PubMedPMID:24294519;PubMedCentralPMCID:PMC3840723.
ZengMC,NiciuMJ,LuckenbaughDA,lonescuDF,MathewsDC,RichardsEM,Franco-ChavesJ,Brutsche
NE,ZarateCAJr.Acutestresssymptomsdonotworseninposttraumaticstressdisorderandabusewith
asinglesubanestheticdoseofketamine.BiolPsychiatry.2013Jun15;73(12):e37-8.doi:
10.1016/j.biopsych.2012.10.017.Epub2012Dec13.PubMedPMID:23245747.
  
ili.ReviewsorEditorialsinRefereedJournals
1lonescuDF,NiciuMJ,RichardsEM,ZarateCAJr.Pharmacologictreatmentofdimensionalanxious
depression:areview.PrimCareCompanionCNSDisord.2014;16(3).pii:PCC.13r01621.doi:   EricaM.Richards,MD,PhD CurriculumVitae	Page6of11
10.4088/PCC.13r01621.Epub2014May29.PubMedPMID:25317369;PubMedCentralPMCID:
PMC4195641.
2.NiciuMJ,MathewsDC,NugentAC,lonescuDF,FureyML,RichardsEM,Machado-VieiraR,ZarateCAJr.
Developingbiomarkersinmooddisordersresearchthroughtheuseofrapid-actingantidepressants.
DepressAnxiety.2014Apr;31(4):297-307.doi:10.1002/da.22224.Epub2013Dec18.Review.PubMed
PMID:24353110;PubMedCentralPMCID:PMC3984598.
3.Machado-VieiraR,Soeiro-De-SouzaMG,RichardsEM,TeixeiraAL,ZarateCAJr.Multiplelevelsof
impairedneuralplasticityandcellularresilienceinbipolardisorder:developingtreatmentsusingan
integratedtranslationalapproach.WorldJBiolPsychiatry.2014Feb;15(2):84-95.doi:
10.3109/15622975.2013.830775.Epub2013Sep2.Review.PubMedPMID:23998912;PubMedCentral
PMCID:PMC4180367.
4.NiciuMJ,MathewsDC,lonescuDF,RichardsEM,FureyML,YuanP,NugentAC,HenterID,Machado-
VieiraR,ZarateCAJr.Biomarkersinmooddisordersresearch:developingnewandimproved
therapeutics.RevPsiquiatrClin.2014;41(5):131-134,PubMedPMID:26082563;PubMedCentralPMCID:
PMC4465361.
5.NiciuMJ,lonescuDF,RichardsEM,ZarateCAJr.Glutamateanditsreceptorsinthepathophysiologyand
treatmentofmajordepressivedisorder.JNeuralTransm(Vienna).2014Aug;121(8):907-24.doi:
10.1007/s00702-013-1130-x.Epub2013Dec8.Review.PubMedPMID:24318540;PubMedCentral
PMCID:PMC4048804.
6.RichardsEM,PayneJL.Themanagementofmooddisordersinpregnancy:alternativesto
antidepressants.CNSSpectr.2013Oct;18(5):261-71.doi:10.1017/S1092852913000151.Epub2013Apr
10.Review.PubMedPMID:23570692.
7.NiciuMJ,lonescuDF,MathewsDC,RichardsEM,ZarateCAJr.Secondmessenger/signaltransduction
pathwaysinmajormooddisorders:movingfrommembranetomechanismofaction,part|:major
depressivedisorder.CNSSpectr.2013Oct;18(5):231-41.doi:10.1017/S1092852913000059.Epub2013
Mar5.Review.PubMedPMID:23462230.
‘MJ,IonescuDF,MathewsDC,RichardsEM,ZarateCAJr.Secondmessenger/signaltransduction
pathwaysinmajormooddisorders:movingfrommembranetomechanismofaction,partIl:bipolar
disorder.CNSSpectr.2013Oct;18(5):242-51.doi:10.1017/S1092852913000138.Epub2013Mar11.
Review.PubMedPMID:23472710;PubMedCentralPMCID:PMC3936782.
9.lonescuDF,NiciuMJ,MathewsDC,RichardsEM,ZarateCAJr.Neurobiologyofanxiousdepression:a
review.DepressAnxiety.2013Apr;30(4):374-85.doi:10.1002/da.22095.Epub2013Mar11.Review.
PubMedPMID:23495126;PubMedCentralPMCID:PMC3698573.
10.FiskumG,DanilovCA,MehrabianZ,BambrickLL,KristianT,McKennaMC,Hopkins|,RichardsEM,
RosenthalRE.Postischemicoxidativestresspromotesmitochondrialmetabolicfailureinneuronsand
astrocytes.AnnNYAcadSci.2008Dec;1147:129-38.doi:10.1196/annals.1427.026.Review.PubMed
PMID:19076438;PubMedCentralPMCID:PMC3040634.
MartinE,RosenthalRE,FiskumG.Pyruvatedehydrogenasecomplex:metaboliclinktoischemicbrain
juryandtargetofoxidativestress.JNeurosciRes.2005Jan1-15;79(1-2):240-7.Review.PubMed
PMID:15562436;PubMedCentralPMCID:PMC2570320.
12.FiskumG,RosenthalRE,VereczkiV,MartinE,HoffmanGE,ChinopoulosC,KowaltowskiA.Protection
againstischemicbraininjurybyinhibitionofmitochondrialoxidativestress.JBioenergBiomembr.2004
Aug;36(4):347-52.Review.PubMedPMID:15377870.
    
     EricaM.Richards,MD,PhD CurriculumVitae	Page7of11
ili.ChaptersinBooksandElectronicChapters
1.ElizabethD.Ballard,EricaM.Richards,DawnF.lonescu,MarkJ.Niciu,JenniferVandeVoortandCarlos
A.ZarateJr.Experimentalpharmacologicapproachesforthereductionofsuicidalideationandbehavior.
InK.E.CannonandT.J.Hudzik(Eds.)Suicide:PhenomenologyandNeurobiology,Switzerland:Springer
InternationalPublishing,2014.
2.EricaM.RichardsandMarylandPao.SleepDisruptions.TheJohnsHopkinsPhippsPsychiatryGuide.
JohnsHopkinsPOC-ITCenter(JohnsHopkinsPointofCareInformationTechnologyCenter),Baltimore,
MD.October,2014.
  
FUNDING
1)Agency:NationalinstitutesofHealthRuthL.KirschsteinNRSAMD/PhD
IdentifyingNumber:F30PredoctoralFellowshipAward
TitleofProject:“ThePyruvateDehydrogenaseComplexasaTargetforOxidativeStressFollowing
Ischemia/Reperfusion”.
DatesofProjectPeriod:February2004-May2006.
CorrespondingPI:EricaMartin(Richards)
TotalDollarAmount:$42,675
RoleonProject:PI
Description:Thispredoctoralfellowshipawardprovidedadditionaltrainingandresearchsupportduring
mydissertationstudyontheeffectsofheartattackandstrokeonthebrain.
PercentEffort:100%
 
2)Agency:AmericanHeartAssociation
IdentifyingNumber:PredoctoralFellowshipAward
TitleofProject:“TheRoleofHypoxiainHippocampalMitochondriaFunctionFollowingCardiacArrest
andResuscitation”
DatesofProjectPeriod:October2001-June2003
CorrespondingPl:EricaMartin(Richards)
TotalDollarAmount:$23,500
RoleonProject:PI
Description:Thispredoctoralfellowshipawardprovidedadditionaltrainingandresearchsupport
duringmydissertationstudyontheeffectsofheartattackandstrokeonthebrain;
specificallyonmitochondrialfunctionfollowingischemia.
PercentEffort:100%
 
CLINICALACTIVITIES
Licensure:State:Maryland
license#:00073634
InitialDate:2/07/12
 
State: DistrictofColumbia
License# MD045656
InitialDate:8/12/17   EricaM.Richards,MD,PhD CurriculumVitae	Page8of11
Certification:‘AmericanBoardofPsychiatryandNeurology
DateofCertification:9/15/14
DateofRecertification:September2024
 
DevelopmentofNational/internationallyRecognizedClinicalStandardofCare:
January2008 ‘AmericanHeartAssociation(AHA)Guidelinesincluderecommendationsforemergency
medicaltechnicianstotitrateinhaledoxygento21%ratherthanpriorstandardsof
100%,citinganarticleforwhich|amfirst-author:RichardsEM,FiskumG,RosenthalRE,
Hopkins|,McKennaMC.“Hyperoxicreperfusionafterglobalischemiadecreases
hippocampalenergymetabolism”.Stroke.2007May;38(5):1578-84.Thisisincludedin
AdvancedCardiopulmonaryLifeSupport(ACLS)Trainingforfirst-responders.
  
EDUCATIONALACTIVITIES
Teaching
ClassroomInstruction
October2016 “ResearchEthics”Didactictrainingforpsychosomaticmedicinefellows.
 
ClinicalInstruction
NameofClerkship:MedstarGeorgetown/NIMHPsychosomaticMedicineFellowship
Role:AttendingPhysician,NIMHFellowshipAttending/ResearchMentor
CMEInstruction
April20,2020 GrandRounds:JohnsHopkinsHospital,Baltimore,MD
November10,2016. GrandRounds:UniversityofMassachusettsMedicalSchool,Worcester,MA.
Mentoring
1)NameofMentee:LauraNewman
DatesofMentorship:July2015-April2017.
Outcomes:Sharedpublications—1.
2)NameofMentee:GenevieveGilson
DatesofMentorship:May2016-August2016.
Outcomes:Accepted,TulaneSchoolofMedicineClassof2021.
3)NameofMentee:TessaWalls
DatesofMentorship:July2013—July2015
Outcome(s):
1)Sharedpublications-1   EricaM.Richards,MD,PhD CurriculumVitae	Page9of11
2)CompletedLoyolaUniversityofMarylandMaster’sPlusPrograminPsychiatry,2016.
ORGANIZATIONALACTIVITIES
InstitutionalAdministrativeAppointments:
2020-presentDCHospitalAssociation:OpioidandSubstanceUseResponseWorkgroup
2017-presentDCHospitalAssociBehavioralHealthCollaborativeGroupMember
2017-presentMember,MedicalExecutiveCommittee,SibleyMemorialHospital
2017-presentMember,PharmacyandTherapeuticsBoard,SibleyMemorialHospital
2017-present~Member,InfectionPreventionHospitalCommittee,SibleyMemorialHospital
2017-2019—Member,QualitySafetyandServiceCommittee,SibleyMemorialHospital
2017-2019Mayor'sOpioidTaskForce,StrategicTeamLead,Washington,DC
2016-2017—Member,NIHIntramuralSeminarSeriesCommittee
2015-2016BoardMember,NationalInstituteofMentalHealthFellowsCommittee
2014-2015FounderandInstructor,ResearchAssistantClinicalTrainingWorkshop
2014-2015NIMHRepresentative,NIHClinicalFellowsCommittee
  
 
ProfessionalSocieties
2015-2019AmericanSocietyofClinicalPsychopharmacology
2009-2019AmericanPsychiatricAssociation
1999-2008
 
RECOGNITION
InvitedTalks/Media:
WorldBreastfeedingWeek,SibleyHospital:Invitedspeaker,“PostpartumDepression”;August2019
\gton,DC)On-AirInterview:“Ketamine-ANewTreatmentforDepression”,April
 
WHUR96.3(Washington,DC)TownKallPanelist:“TheOpioidCrisis”,March2019
Fox5MorningLocalNews(Washington,DC)On-AirInterview:“BipolarDisorder”,April2018
CBS“OffScriptwithBruceJohnson”On-AirInterview:BipolarDisorder,April2018
GrandRounds:“DepressionandInflammation:HowdoWeCalmtheFire?”.HowardUniversity.
Washington,DCMarch2018.
  
GrandRounds:“Biomarkers,BrainDiseaseandInflammation”.UniversityofMassachusettsMedical
‘School,Worcester,MA.November2016.
Symposiumspeaker:“PETimagingandNeuroinflammation”.AmericanCollegeof
Neuropsychopharmacology(ACNP)meeting.Hollywood,FL.December2015.   EricaM.Richards,MD,PhD CurriculumVitae	Page10of11,
Keynotespeaker:“NewOptionsfortheTreatmentofDepression”.NationalAllianceonMentalIllness
(NAMI)AnnualConference,Huron,SD.October2015.
Keynotespeaker:“NavigatingYourPathTowardsaCareerinScience”.AllianceforGraduateEducation
andtheProfessoriate(AGEP)ResearchSymposium,CollegePark,MD.January2006.
Awards,Honors
TopPosterAward—ClinicalResearch,SocietyofBiologicalPsychiatry(SOBP),2016
TravelAward,AmericanCollegeofNeuropsychopharmacology(ACNP),2015
NewInvestigatorAward,AmericanSocietyforClinicalPsychopharmacology(ASCP),2015
YoungInvestigatorAward,CareerDevelopmentInstitute(CDI)forBipolarDisorder,2015
InvitedFellow,NIMHBrainCamp,2014
InternoftheYearAward,JohnsHopkinsBayviewDepartmentofPsychiatry,2009
FirstPlace,OralPresentation,UniversityofMarylandGraduateStudentResearchDay,2005
MD/PhDOutstandingScholarAward,UniversityofMaryland,Baltimore,1999
PhiBetaKappa,EpsilonofGeorgia,1999
GoldenKeyNationalHonorSociety,1999
MortarBoardSeniorHonorSociety,1998
NationalinstitutesofHealthUndergraduateScholarshipRecipient,1997,1998
Member,AlphaLambdaDeltaHonorSociety,1997
Captain,SpelmanCollegeSoccerTeam,1996-1998
 
OTHERPROFESSIONALACCOMPLISHMENTS
RichardsEM,Zanotti-FregonaraP,FujitaM,Walls,NiciuMJ,ParkM,Machado-VieiraR,SalvadoreG,
KolbH,ZarateCA,InnisRB.“IncreasedPETradioligandbindingtotranslocatorproteinsuggeststhat
majordepressivedisorderisassociatedwithneuroinflammation”.Posterpresentation,Societyof
BiologicalPsychiatry.Toronto,Canada.May2015.
RichardsEM,BallardED,NiciuMJ,VandeVoortJ,LuckenbaughDA,ZarateCA.“GenderDifferencesin
AntidepressantResponsetoKetamine”.PosterPresentation,SixthWorldCongressonWomen’sMental
Health.Tokyo,Japan.March2015.
RichardsEM,MathewsD,Machado-VieiraR,NiciuM,lonescuD,NolanN,Franco-ChavesJ,HudzikT,
MaciagC,ShuangL,SmithM,LuckenbaughDA,Zarate,JrC.“ARandomized,Placebo-Controlled,Pilot
TrialofaDeltaOpioidAgonistinPatientswithAnxiousMajorDepression”.Posterpresentation,Society
ofBiologicalPsychiatry.NewYork,NY.May2014.
 
Martin€,VereczkiV,RosenthalR,andFiskumG.“TargetingofthePyruvateDehydrogenaseComplexby
OxidativeStressduringCerebralIschemia/Reperfusion”.Abstractprintedandposterpresentatedat
SocietyforNeuroscienceConference.SanDiego,CA.October2004.
MartinE,VereczkiV,RosenthalRandFiskumG.“ThePyruvateDehydrogenaseComplexasaTargetof
OxidativeStressDuringCerebralischemia/Reperfusion”.Invitedtalk,Mitochondriaand
NeuroprotectionSymposium.Ft.Lauderdale,FL.April2004.   EricaM.Richards,MD,PhD CurriculumVitae	Page11of11
MartinE,RicePandHasdayJ.“TheInfluenceofFeveronSurvivalDuringanAntibiotic-Treated
PneumoniaInfection”.MedicalStudentResearchDay.Baltimore,MD.2000   
Executive Office of the Mayor – Mayor’s Office of Talent and Appointments 
John A. Wilson Building | 1350 Pennsylvania Avenue, Suite 600 | Washington, DC 20004 
 
   
 
 
Erica Richards, M.D., Ph.D. 
 
Dr. Erica Richards is a board-certified adult psychiatrist. She is 
currently the chair and medical director of the Department of Psychiatry 
and Behavioral Health at Sibley Memorial Hospital, as well as an 
assistant professor in the Department of Psychiatry and Behavioral 
Sciences at the Johns Hopkins University School of Medicine. Dr. 
Richards is board certified in psychiatry by the American Board of 
Psychiatry and Neurology.   
Dr. Richards is a member of the American Society of Clinical 
Psychopharmacology and the American Psychiatric Association. She 
previously served as the founder and instructor for the Research 
Assistant Clinical Training Workshop, a National Institute of Mental Health representative for the 
National Institutes of Health Clinical Fellows Committee, and a board member for the National 
Institute of Mental Health Fellows Committee.   
Dr. Richards has earned the Top Poster Award for Clinical Research by the Society of Biological 
Psychiatry; a Travel Award by the American College of Neuropsychopharmacology, 	a Young 
Investigator Award by the Career Development Institute for Bipolar Disorder, a New Investigator 
Award for the American Society of Clinical Psychopharmacology, 	as well as several other 
distinctions during her years of study.   
Dr. Richards has contributed to numerous publications with her research interests on investigating 
the role of inflammation in the pathophysiology of mood disorders, identifying potential 
biomarkers of depression and treatment response, and elucidating the mechanism of action of 
ketamine's antidepressant effects. The National Institutes of Health and the American Heart 
Association have both provided funding for her research on the effects of heart attack and stroke 
on the brain, specifically on mitochondrial function following ischemia. 	She has authored over 30 
peer-reviewed research publications in the fields of neuroscience and psychiatry research.  
A Ward 4 resident, Dr. Richards earned her Bachelor of Science in Biology from Spelman College 
and both her PhD in Neuroscience and her Doctor of Medicine from University of Maryland.     GOVERNMENT OF THE DISTRICT OF COLUMBIA 
Executive Office of Mayor Muriel Bowser 
 
Office of the General Counsel to the Mayor 
 
 
______________________________________________________________________________ 
The John A. Wilson Building     •    1350 Pennsylvania Avenue, NW     •     Suite 300    •   Washington, D.C.  20004     •    Office (202) 724-7681 
 
To:   Kimberly A. Bassett, Steve Walker 
From:   Betsy Cavendish 
Date:   October 7, 2024 
Subject:  Legal sufficiency review of a resolution reappointing Dr. Erica Richards as a 
member of the Violence Fatality Review Committee 
This is to Certify that this office has reviewed the above-referenced Order and found 
it to be legally unobjectionable.  If you have any questions in this regard, please do not hesitate 
to call Michael Porcello, Deputy General Counsel, Executive Office of the Mayor, at 202-727-
0872, or me at 202-724-7681. 
 
 
 
 
______________________________ 
Elizabeth Cavendish